Late rectal toxicity on RTOG 94-06: Analysis using a mixture lyman model

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 4, 2010, Pages 1253-1260

  Tucker, Susan L ^a   Dong, Lei ^a   Bosch, Walter R ^b,c   Michalski, Jeff ^c   Winter, Kathryn ^d   Mohan, Radhe ^a   Purdy, James A ^e   Kuban, Deborah ^a   Lee, Andrew K ^a   Cheung, M Rex ^a   Thames, Howard D ^a   Cox, James D ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d AMERICAN COLLEGE OF RADIOLOGY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dose volume histogram; Lyman model; Prostate cancer; Radiation Therapy Oncology Group; Rectal toxicity

Indexed keywords

DOSE-VOLUME HISTOGRAMS; LYMAN MODEL; PROSTATE CANCERS; RADIATION THERAPY ONCOLOGY GROUP; RECTAL TOXICITY;

DISEASES; DOSIMETRY; GRAPHIC METHODS; ONCOLOGY; PATIENT MONITORING; PROBABILITY; STATISTICAL METHODS; THREE DIMENSIONAL; TOXICITY;

RADIOTHERAPY;

ARTICLE; CANCER HORMONE THERAPY; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DIABETES MELLITUS; FOLLOW UP; HUMAN; HYPERTENSION; LYMAN KUTCHER BURMAN MODEL; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MAXIMUM TOLERATED DOSE; MIXTURE LYMAN MODEL; MORBIDITY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RECTUM TOXICITY; ANATOMY AND HISTOLOGY; BIOLOGICAL MODEL; COMPLICATION; DIABETES COMPLICATIONS; INCIDENCE; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIATION RESPONSE; RECTUM; STATISTICAL MODEL; TIME;

CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MAXIMUM TOLERATED DOSE; MODELS, BIOLOGICAL; MODELS, STATISTICAL; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; RECTUM; TIME FACTORS;

EID: 77958499583     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.01.069     Document Type: Article

References (35)

1. T. Rancati, C. Fiorino, and G. Gagliardi Fitting late rectal bleeding data using different NTCP models: Results from an Italian multi-centric study (AIROPROS0101) Radiother Oncol 73 2004 21 32
2. R. Cheung, S.L. Tucker, and J.S. Ye Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 58 2004 1513 1519
3. S.T.H. Peeters, M.S. Hoogeman, and W.D. Heemsbergen Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 66 2006 11 19
4. M. Söhn, D. Yan, and J. Liang Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models Int J Radiat Oncol Biol Phys 67 2007 1066 1073
5. J.T. Lyman Complication probability as assessed from dose-volume histograms Radiat Res Suppl 8 1985 S13 S19
6. G.J. Kutcher, and C. Burman Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method Int J Radiat Oncol Biol Phys 16 1989 1623 1630
7. S.L. Tucker, H.H. Liu, and Z. Liao Analysis of radiation pneumonitis risk using a generalized Lyman model Int J Radiat Oncol Biol Phys 72 2008 568 574
8. P.C. Lambert, J.R. Thompson, and C.L. Weston Estimating and modeling the cure fraction in population-based cancer survival analysis Biostatistics 8 2007 576 594
9. J.M. Michalski, K. Winter, and J.A. Purdy Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II Int J Radiat Oncol Biol Phys 56 2003 192 198
10. J.K. Ryu, K. Winter, and J.M. Michalski Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III Int J Radiat Oncol Biol Phys 54 2002 1036 1046 (Pubitemid 35292614)
11. J.M. Michalski, K. Winter, and J.A. Purdy Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV Int J Radiat Oncol Biol Phys 58 2004 735 742
12. J.M. Michalski, K. Winter, and J.A. Purdy Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose level V Int J Radiat Oncol Biol Phys 62 2005 706 713
13. M. Roach Equation for predicting the pathologic stage of men with localized prostate cancer using the preoperative prostate specific antigen (PSA) and Gleason score J Urol 150 1993 1923 1924
14. S.L. Tucker, L. Dong, and R. Cheung Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy Int J Radiat Oncol Biol Phys 60 2004 1589 1601
15. S.N. Rasmussen, and P. Riis Rectal wall thickness measured by ultrasound in chronic inflammatory diseases of the colon Scand J Gastroenterol 20 1985 109 114
16. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
17. R. Mohan, G.S. Mageras, and B. Baldwin Clinically relevant optimization of 3-D conformal treatments Med Phys 19 1992 933 944
18. B.J.T. Morgan Analysis of Quantal Response Data 1992 Chapman & Hall New York
19. M. Greenwood The natural duration of cancer Reports on Public Health and Medical Subjects 33 1926 1 26
20. J.M. Michalski, H. Gay, and A. Jackson Radiation dose-volume effects in radiation-induced rectal injury Int J Radiat Oncol Biol Phys 76 Suppl. 3 2010 S123 S129
21. S.L. Tucker, L. Dong, and W.R. Bosch Fit of a generalized Lyman normal-tissue complication probability (NTCP) model to grade ≥2 late rectal toxicity data from patients treated on protocol RTOG 94-06 Int J Radiat Oncol Biol Phys 69 Suppl.1 2007 S8
22. http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ ctcaev3.pdf
23. P.C.M. Koper, W.D. Heemsbergen, and M.S. Hoogeman Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer Int J Radiat Oncol Biol Phys 58 2004 1072 1082
24. S.T.H. Peeters, W.D. Heemsbergen, and W.L.J. van Putten Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy Int J Radiat Oncol Biol Phys 61 2005 1019 1034
25. K.S. Choe, A.B. Jani, and S.L. Liauw External beam radiotherapy for prostate cancer patients on anticoagulation therapy: How significant is the bleeding toxicity? Int J Radiat Oncol Biol Phys 76 2010 755 760
26. C. Fiorino, G. Fellin, and T. Rancati Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: Preliminary results of a multicenter prospective study Int J Radiat Oncol Biol Phys 70 2008 1130 1137
27. C. Fiorino, G. Sanguinetti, and C. Cozzarini Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer Int J Radiat Oncol Biol Phys 57 2003 953 962
28. M. Liu, T. Pickles, and A. Agranovich Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy Int J Radiat Oncol Biol Phys 58 2004 59 67
29. C. Vargas, A. Martinez, and L.L. Kestin Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy Int J Radiat Oncol Biol Phys 62 2005 1297 1308
30. D.M. Herold, A.L. Hanlon, and G.E. Hanks Diabetes mellitus: A predictor for late radiation morbidity Int J Radiat Oncol Biol Phys 43 1999 475 479
31. M.W. Skwarchuk, A. Jackson, and M.J. Zelefsky Late rectal toxicity after conformal radiotherapy of prostate cancer (I): Multivariate analysis and dose-response Int J Radiat Oncol Biol Phys 47 2000 103 113
32. T.E. Schultheiss, R. Lee, and M.A. Hunt Late GI and GU complications in the treatment of prostate cancer Int J Radiat Oncol Biol Phys 37 1997 3 11
33. T.E. Schultheiss, G.E. Hanks, and M.A. Hunt Influence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate Int J Radiat Oncol Biol Phys 32 1995 643 649
34. R.K. Valicenti, K. Winter, and J.D. Cox RTOG 94-06: Is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity? Int J Radiat Oncol Biol Phys 57 2003 614 620
35. J.M. Michalski, K. Bae, and M. Roach Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study Int J Radiat Oncol Biol Phys 76 2010 14 22